Phosphodiesterase 5 inhibitors in vascular systemic disorders

被引：4
|
作者：
Allanore, Yannick [1 ]
机构：
[1] Univ Paris 05, INSERM U1016, Serv Rhumatol, Hop Cochin, F-75014 Paris, France
来源：
JOINT BONE SPINE | 2012年 / 79卷 / 04期
关键词：
Phosphodiesterase; Nitric oxide; Pulmonary hypertension; Raynaud's phenomenon; Sildenafil; Tadalafil; PULMONARY ARTERIAL-HYPERTENSION; RAYNAUDS-PHENOMENON RESISTANT; DOUBLE-BLIND; SILDENAFIL; THERAPY; TADALAFIL; SCLEROSIS; EFFICACY;
D O I：
10.1016/j.jbspin.2011.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：338 / 340
页数：3
相关论文
共 50 条
  • [1] Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders
    Kumar, Ashish
    Kim, Fred
    Song, Dong-Keun
    Choung, Jai Jun
    AGING AND DISEASE, 2024, 15 (05): : 2008 - 2014
  • [2] Phosphodiesterase inhibitors in psychiatric disorders
    Sadeghi, Mohammad Amin
    Nassireslami, Ehsan
    Zoshk, Mojtaba Yousefi
    Hosseini, Yasaman
    Abbasian, Kourosh
    Chamanara, Mohsen
    PSYCHOPHARMACOLOGY, 2023, 240 (06) : 1201 - 1219
  • [3] Phosphodiesterase inhibitors in psychiatric disorders
    Mohammad Amin Sadeghi
    Ehsan Nassireslami
    Mojtaba Yousefi Zoshk
    Yasaman Hosseini
    Kourosh Abbasian
    Mohsen Chamanara
    Psychopharmacology, 2023, 240 : 1201 - 1219
  • [4] Phosphodiesterase 5 inhibitors
    Stamford, AW
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 53 - 64
  • [5] Phosphodiesterase 5 inhibitors
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2013, 52 (530): : 51 - 54
  • [6] Vision Disorders and Phosphodiesterase Type 5 Inhibitors A Review of the Evidence to Date
    Laties, Alan M.
    DRUG SAFETY, 2009, 32 (01) : 1 - 18
  • [7] Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: An update review
    Singh, Niraj Kumar
    Singh, Pranjul
    Varshney, Prachi
    Singh, Ashini
    Bhushan, Bharat
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (11)
  • [8] Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann, Thorsten
    Kloner, Robert A.
    CARDIOVASCULAR RESEARCH, 2009, 83 (02) : 204 - 212
  • [9] PHOSPHODIESTERASE INHIBITORS - ALTERATIONS IN SYSTEMIC AND CORONARY HEMODYNAMICS
    CHATTERJEE, K
    BASIC RESEARCH IN CARDIOLOGY, 1989, 84 : 213 - 224
  • [10] EFFECT OF ISOFLAVONES ON THE VASCULAR ACTIONS OF PHOSPHODIESTERASE INHIBITORS
    Kwong, Alison W. S.
    Leung, Susan W. S.
    Man, Ricky Y. K.
    JOURNAL OF VASCULAR RESEARCH, 2012, 49 : 31 - 31
12345